The COVID Booster Vaccine Discussion Is Far from Over

September 20, 2021

(Axios) – An FDA advisory panel may have green-lit a third shot of the Pfizer vaccine for a somewhat narrow slice of the population, but the messy process of figuring out who should get another shot of the vaccine — and when — has likely just begun. Why it matters: Many vaccinated Americans are worried about their level of protection as the pandemic continues to rage. The piecemeal booster decision-making process may be the best way to keep pace with the science, but it’s also at risk of becoming extremely confusing. (Read Full Article)